8-K/A

8-K AMENDMENT NO 1

Company: Eledon Pharmaceuticals, Inc.
Filed: November 20, 2020
Period of Report: September 9, 2020
Accession Number: 0001193125-20-298749

View Document ↗ View on SEC.gov ↗